264 filings
Page 8 of 14
4
zx9ufvhifhyi88
16 Oct 20
Change in insider ownership
9:30pm
8-K
of4uwyvh
16 Oct 20
Eton Pharmaceuticals Announces Closing of Public Offering
5:24pm
424B5
ityrs juw7vridsgo6u
15 Oct 20
Prospectus supplement for primary offering
4:50pm
8-K
kkzkj4bbk6ud5cy
15 Oct 20
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Zonisamide Oral Suspension
9:15am
8-K
btsx3cvkdk3oilsazl
14 Oct 20
Eton Pharmaceuticals Announces Proposed Public Offering of Common Stock
8:53am
424B5
pakk1i
13 Oct 20
Prospectus supplement for primary offering
4:21pm
8-K
c8aqho0z973tl
8 Oct 20
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Orphan Drug Dehydrated Alcohol Injection
9:05am
8-K
o9gq6qq
6 Oct 20
Other Events
4:56pm
8-K
lg3jul3 xbtr2e8
30 Sep 20
Other Events
6:15am
8-K
oskmn9d8 b60tnysje69
25 Sep 20
Other Events
8:23am
8-K
3s6v196whobfv t7ad
16 Sep 20
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
9:28am
8-K
qiuqqmo4m2 c9p8uz
31 Aug 20
Eton Pharmaceuticals Announces Appointment of Ingrid Hoos as Senior Vice President of Scientific Affairs
9:25am
EFFECT
93p q8nfjjeqa7
26 Aug 20
Notice of effectiveness
12:15am
CORRESP
nmovs0xaw
24 Aug 20
Correspondence with SEC
12:00am
8-K
8zfobx
12 Aug 20
Eton Pharmaceuticals Announces Second Quarter 2020 Financial Results
8:52am
8-K
9tz3 b6i3by997e
11 Aug 20
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
9:21am
UPLOAD
p679e2kxqacd3
4 Aug 20
Letter from SEC
12:00am
8-K
0j30 cd4ra0u2k
31 Jul 20
Other Events
4:25pm